SCHEMBL30173009

SCHEMBL30173009

CN1CCC[C@H]1c1cc(C2CCOC2)cnc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4292585 0.74 JAK2 (0.44)
SCHEMBL17913130 0.74
SCHEMBL30173057 0.70 CHRNB2 (0.35)
SCHEMBL30711685 0.69 MAP3K12 (0.40)
SCHEMBL30001152 0.68 PRMT5 (0.35)
SCHEMBL20242476 0.68 PRMT5 (0.35)
SCHEMBL26585987 0.68 PIK3CA (0.39)
SCHEMBL24993450 0.66 CHRNB2 (0.40)
SCHEMBL7696565 0.66 CHRNB2 (0.51)
SCHEMBL7696569 0.66 CHRNB2 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4380565-A1 HPK1 ANTAGONISTS AND USES THEREOF Nimbus Saturn, Inc. (US) 2024-06-12 EP disclosed
CN-117915912-A HPK1 antagonists and uses thereof 林伯士萨顿公司 2024-04-19 CN disclosed
WO-2023015199-A1 HPK1 ANTAGONISTS AND USES THEREOF Nimbus Saturn, Inc. (US) 2023-02-09 WO disclosed